Denali Therapeutics Stock (NASDAQ: DNLI) stock price, news, charts, stock research, profile.
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Other companies in Denali Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
Denali Therapeutics has a consensus price target of $43.31.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $30.89 last updated September 24, 2024 at 4:08 PM EDT.
There are no upcoming dividends for Denali Therapeutics.
Denali Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.